Beta Drugs Ltd. BETA

NSE · India · Health Technology

INR 2,073.30+20.30 (+0.99%)

Market closed· Oct 1, 2026, 9:59 AM UTC· INR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Beta Drugs Ltd. BETA

NSE · India · Health Technology

INR 2,073.30+20.30 (+0.99%)

Market closed· Oct 1, 2026, 9:59 AM UTC· INR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

+63.24% · 6MFull-screen chart

Open INR 2,030.00High INR 2,088.50Low INR 2,020.00Close INR 2,073.30Volume 8.70K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: INR 2,053.00
Day range: INR 2,020.00 – INR 2,088.50
52-week range: INR 990.10 – INR 2,807.90
Volume: 8.70K
Market cap: INR 22.76B
P/E (TTM): 47.0
Next earnings date: 2026-10-28
Avg. volume (1Y): 21.82K

Performance

1 week

-6.16%

1 month

-9.16%

3 months

-4.76%

6 months

+32.54%

Year to date

+32.85%

1 year

+13.05%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: India
Exchange: NSE
Shares outstanding: 11.09M
Employees: 455
ISIN: INE351Y01019
Beta: 0.83

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceNov 10, 2025

Beta Drugs Ltd (NSE:BETA) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Margin ...

Beta Drugs Ltd (NSE:BETA) reports a 13% sales increase and improved EBITDA margins, despite facing challenges in gross profit margins and international business growth.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.